MEDIFAST is a personal services business based in the US. MEDIFAST shares (MED) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $14.15 – a decrease of 1.39% over the previous week. MEDIFAST employs 504 staff and has a trailing 12-month revenue of around $602.5 million.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – MED.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy MEDIFAST stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
MEDIFAST stock price (NYSE: MED)
Use our graph to track the performance of MED stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
MEDIFAST price performance over time
Historical closes compared with the close of $14.34 from 2025-03-21
1 week (2025-03-17)
-0.07%
1 month (2025-02-25)
-0.35%
3 months (2024-12-24)
-15.50%
6 months (2024-09-25)
-22.07%
1 year (2024-03-22)
-58.67%
2 years (2023-03-24)
-84.42%
3 years (2022-03-24)
154.5215
5 years (2020-03-25)
55.2061
Is MEDIFAST stock undervalued or overvalued?
Valuing MEDIFAST stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MEDIFAST's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MEDIFAST's P/E ratio
MEDIFAST's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 75x. In other words, MEDIFAST shares trade at around 75x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
MEDIFAST's PEG ratio
MEDIFAST's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MEDIFAST's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MEDIFAST's EBITDA
MEDIFAST's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $18.9 million.
The EBITDA is a measure of a MEDIFAST's overall financial performance and is widely used to measure a its profitability.
MEDIFAST financials
Revenue TTM
$602.5 million
Operating margin TTM
0.6%
Gross profit TTM
$444.6 million
Return on assets TTM
3.24%
Return on equity TTM
1.02%
Profit margin
0.35%
Book value
$19.71
Market Capitalization
$157.1 million
TTM: trailing 12 months
MEDIFAST share dividends
We're not expecting MEDIFAST to pay a dividend over the next 12 months.
MEDIFAST share price volatility
Over the last 12 months, MEDIFAST's shares have ranged in value from as little as $13.57 up to $39.14. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MEDIFAST's is 1.165. This would suggest that MEDIFAST's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
MEDIFAST overview
Medifast, Inc. , through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
Frequently asked questions
What percentage of MEDIFAST is owned by insiders or institutions? Currently 2.532% of MEDIFAST shares are held by insiders and 83.351% by institutions.How many people work for MEDIFAST? Latest data suggests 504 work at MEDIFAST.When does the fiscal year end for MEDIFAST? MEDIFAST's fiscal year ends in December.Where is MEDIFAST based? MEDIFAST's address is: 100 International Drive, Baltimore, MD, United States, 21202What is MEDIFAST's ISIN number? MEDIFAST's international securities identification number is: US58470H1014What is MEDIFAST's CUSIP number? MEDIFAST's Committee on Uniform Securities Identification Procedures number is: 42221F101
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
